Orbital implant exposure following enucleation or evisceration

Huda Abdullah Al-Farsi, Buthaina Sabt, Abdullah Al-Mujaini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PURPOSE: To study the exposure rate of orbital implant postenucleation or evisceration procedures in two tertiary hospitals in Oman. DESIGN: A retrospective, descriptive, cross-section study. MATERIALS AND METHODS: Patients' records were reviewed for patients' demographics, surgical indications, implant types, follow-up and any reported complications after surgeries. Patients with a minimum of 1 year follow-up period were selected. All patients who underwent enucleation or evisceration with primary orbital implant were included in the study. Patients who underwent secondary orbital implant were excluded from the study. RESULTS: A total of 37 patients (age between 4 and 88-year-old, median age is 54-year-old) underwent enucleation or evisceration during 2008-2014. The most common indications for the surgical intervention were painful blind eye (35%), followed by trauma (16%), and perforated corneal ulcer (16%). Out of 37 patients, hydroxyapatite implant was implanted in 17 patients (46%), a glass or acrylic implant was implanted in 17 patients (46%), bioceramic implant was implanted in two patients (5%), and Molteno prosthesis was implanted in one patient (3%). There was no case of orbital implant exposure in any patients in this study. CONCLUSIONS: No orbital implant exposure was recorded in this study. The surgical technique, end to end rectus muscles suturing, used for enucleation/evisceration was the main reason for reduced implant exposure. In addition, the preexisting ocular pathology did not affect the outcome of the study.

Original languageEnglish
Pages (from-to)87-90
Number of pages4
JournalOman Journal of Ophthalmology
Volume10
Issue number2
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Orbital Implants
Orbit Evisceration
Oman
Corneal Ulcer
Durapatite
Tertiary Care Centers
Prostheses and Implants

Keywords

  • Enucleation/evisceration procedures
  • glass/acrylic implant
  • hydroxyapatite implant
  • orbital implant exposure

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Orbital implant exposure following enucleation or evisceration. / Al-Farsi, Huda Abdullah; Sabt, Buthaina; Al-Mujaini, Abdullah.

In: Oman Journal of Ophthalmology, Vol. 10, No. 2, 01.05.2017, p. 87-90.

Research output: Contribution to journalArticle

Al-Farsi, Huda Abdullah ; Sabt, Buthaina ; Al-Mujaini, Abdullah. / Orbital implant exposure following enucleation or evisceration. In: Oman Journal of Ophthalmology. 2017 ; Vol. 10, No. 2. pp. 87-90.
@article{cd95a21ee6ac43fdb841368807d0e3ce,
title = "Orbital implant exposure following enucleation or evisceration",
abstract = "PURPOSE: To study the exposure rate of orbital implant postenucleation or evisceration procedures in two tertiary hospitals in Oman. DESIGN: A retrospective, descriptive, cross-section study. MATERIALS AND METHODS: Patients' records were reviewed for patients' demographics, surgical indications, implant types, follow-up and any reported complications after surgeries. Patients with a minimum of 1 year follow-up period were selected. All patients who underwent enucleation or evisceration with primary orbital implant were included in the study. Patients who underwent secondary orbital implant were excluded from the study. RESULTS: A total of 37 patients (age between 4 and 88-year-old, median age is 54-year-old) underwent enucleation or evisceration during 2008-2014. The most common indications for the surgical intervention were painful blind eye (35{\%}), followed by trauma (16{\%}), and perforated corneal ulcer (16{\%}). Out of 37 patients, hydroxyapatite implant was implanted in 17 patients (46{\%}), a glass or acrylic implant was implanted in 17 patients (46{\%}), bioceramic implant was implanted in two patients (5{\%}), and Molteno prosthesis was implanted in one patient (3{\%}). There was no case of orbital implant exposure in any patients in this study. CONCLUSIONS: No orbital implant exposure was recorded in this study. The surgical technique, end to end rectus muscles suturing, used for enucleation/evisceration was the main reason for reduced implant exposure. In addition, the preexisting ocular pathology did not affect the outcome of the study.",
keywords = "Enucleation/evisceration procedures, glass/acrylic implant, hydroxyapatite implant, orbital implant exposure",
author = "Al-Farsi, {Huda Abdullah} and Buthaina Sabt and Abdullah Al-Mujaini",
year = "2017",
month = "5",
day = "1",
doi = "10.4103/ojo.OJO_156_2016",
language = "English",
volume = "10",
pages = "87--90",
journal = "Oman Journal of Ophthalmology",
issn = "0974-620X",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

TY - JOUR

T1 - Orbital implant exposure following enucleation or evisceration

AU - Al-Farsi, Huda Abdullah

AU - Sabt, Buthaina

AU - Al-Mujaini, Abdullah

PY - 2017/5/1

Y1 - 2017/5/1

N2 - PURPOSE: To study the exposure rate of orbital implant postenucleation or evisceration procedures in two tertiary hospitals in Oman. DESIGN: A retrospective, descriptive, cross-section study. MATERIALS AND METHODS: Patients' records were reviewed for patients' demographics, surgical indications, implant types, follow-up and any reported complications after surgeries. Patients with a minimum of 1 year follow-up period were selected. All patients who underwent enucleation or evisceration with primary orbital implant were included in the study. Patients who underwent secondary orbital implant were excluded from the study. RESULTS: A total of 37 patients (age between 4 and 88-year-old, median age is 54-year-old) underwent enucleation or evisceration during 2008-2014. The most common indications for the surgical intervention were painful blind eye (35%), followed by trauma (16%), and perforated corneal ulcer (16%). Out of 37 patients, hydroxyapatite implant was implanted in 17 patients (46%), a glass or acrylic implant was implanted in 17 patients (46%), bioceramic implant was implanted in two patients (5%), and Molteno prosthesis was implanted in one patient (3%). There was no case of orbital implant exposure in any patients in this study. CONCLUSIONS: No orbital implant exposure was recorded in this study. The surgical technique, end to end rectus muscles suturing, used for enucleation/evisceration was the main reason for reduced implant exposure. In addition, the preexisting ocular pathology did not affect the outcome of the study.

AB - PURPOSE: To study the exposure rate of orbital implant postenucleation or evisceration procedures in two tertiary hospitals in Oman. DESIGN: A retrospective, descriptive, cross-section study. MATERIALS AND METHODS: Patients' records were reviewed for patients' demographics, surgical indications, implant types, follow-up and any reported complications after surgeries. Patients with a minimum of 1 year follow-up period were selected. All patients who underwent enucleation or evisceration with primary orbital implant were included in the study. Patients who underwent secondary orbital implant were excluded from the study. RESULTS: A total of 37 patients (age between 4 and 88-year-old, median age is 54-year-old) underwent enucleation or evisceration during 2008-2014. The most common indications for the surgical intervention were painful blind eye (35%), followed by trauma (16%), and perforated corneal ulcer (16%). Out of 37 patients, hydroxyapatite implant was implanted in 17 patients (46%), a glass or acrylic implant was implanted in 17 patients (46%), bioceramic implant was implanted in two patients (5%), and Molteno prosthesis was implanted in one patient (3%). There was no case of orbital implant exposure in any patients in this study. CONCLUSIONS: No orbital implant exposure was recorded in this study. The surgical technique, end to end rectus muscles suturing, used for enucleation/evisceration was the main reason for reduced implant exposure. In addition, the preexisting ocular pathology did not affect the outcome of the study.

KW - Enucleation/evisceration procedures

KW - glass/acrylic implant

KW - hydroxyapatite implant

KW - orbital implant exposure

UR - http://www.scopus.com/inward/record.url?scp=85021809316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021809316&partnerID=8YFLogxK

U2 - 10.4103/ojo.OJO_156_2016

DO - 10.4103/ojo.OJO_156_2016

M3 - Article

AN - SCOPUS:85021809316

VL - 10

SP - 87

EP - 90

JO - Oman Journal of Ophthalmology

JF - Oman Journal of Ophthalmology

SN - 0974-620X

IS - 2

ER -